수면무호흡증 진단 시스템 시장 : 제품 유형, 최종사용자, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

Persistence Market Research presents a comprehensive analysis of the global Sleep Apnea Diagnostic Systems Market, offering valuable insights into market dynamics, growth drivers, challenges, and emerging trends. This report delivers exclusive data and statistics projecting the market's trajectory from 2023 to 2030.

The global sleep apnea diagnostic systems market is forecast to expand at a CAGR of 7% and thereby increase from a value of US$3.9 Bn in 2023, to US$6.3 Bn by the end of 2030..

Key Insights:

• Sleep Apnea Diagnostic Systems Market Size (2023E): US$3.9 Billion
• Projected Market Value (2030F): US$6.3 Billion
• Global Market Growth Rate (CAGR 2023 to 2030): 7.0%
• Historical Market Growth Rate (CAGR 2018 to 2022): 4.9%

Sleep Apnea Diagnostic Systems Market - Report Scope:

The Sleep Apnea Diagnostic Systems Market comprises a range of diagnostic tools and equipment crucial for identifying sleep-related breathing disorders such as obstructive sleep apnea. These systems include polysomnography devices, home sleep apnea testing kits, and related accessories. Market growth is primarily driven by the rising prevalence of sleep apnea, increasing awareness about its health implications, and advancements in diagnostic technologies. Additionally, the growing adoption of home sleep testing devices due to their convenience and cost-effectiveness fuels market expansion.

Market Growth Drivers:

The prevalence of sleep apnea continues to rise globally, propelled by factors such as obesity, sedentary lifestyles, and aging populations. This prevalence, coupled with increased awareness among healthcare professionals and patients, drives the demand for diagnostic systems. Technological advancements in sleep apnea diagnostic devices, such as portable monitoring systems and cloud-based data analytics, enhance diagnostic accuracy and patient comfort, further boosting market growth.

Market Restraints:

Despite significant growth opportunities, the Sleep Apnea Diagnostic Systems Market faces challenges related to reimbursement policies, particularly in emerging economies. Limited access to healthcare facilities and diagnostic services in rural areas also impedes market growth. Moreover, the high cost associated with diagnostic equipment and the complexity of interpretation hinder market penetration, especially in developing regions.

Market Opportunities:

The Sleep Apnea Diagnostic Systems Market offers lucrative opportunities driven by technological innovations and increasing emphasis on home-based sleep testing. Integration of artificial intelligence (AI) and machine learning algorithms in diagnostic devices enables automated analysis and interpretation of sleep data, facilitating early detection and personalized treatment strategies. Additionally, collaborations between device manufacturers and healthcare providers to develop affordable diagnostic solutions tailored to specific market needs create avenues for market expansion.

Key Questions Answered in the Report:

• Which regions are likely to witness the highest adoption of sleep apnea diagnostic systems?
• What factors influence patient preferences for home sleep testing versus in-laboratory polysomnography?
• How are technological advancements reshaping the competitive landscape of the sleep apnea diagnostic systems market?
• Who are the key players driving innovation and market expansion in the sleep apnea diagnostic systems segment?
• What are the emerging trends and future prospects in the global sleep apnea diagnostic systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Sleep Apnea Diagnostic Systems Market, including Koninklijke Philips N.V., Becton, Dickinson and Company, Braedon Medical Corporation, and Advanced Brain Monitoring Inc., focus on product innovation and strategic collaborations to maintain market leadership. These companies invest in research and development to introduce advanced diagnostic solutions, expand their product portfolios, and gain a competitive edge. Partnerships with healthcare providers, sleep clinics, and telemedicine platforms enhance market reach and customer engagement. Moreover, investments in marketing initiatives and patient education programs contribute to market growth and brand loyalty.

Key Companies Profiled:

• Koninklijke Philips N.V.
• Becton, Dickinson and Company
• Braedon Medical Corporation
• Advanced Brain Monitoring Inc.
• SOMNOmedics GmbH
• ResMed Inc.
• BMC Medical Co. Ltd.
• Natus Medical Incorporated
• MGC Diagnostics Corporation
• Cleveland Medical Devices Inc.

Sleep Apnea Diagnostic Systems Market Research Segmentation:

The Sleep Apnea Diagnostic Systems Market is segmented based on the type of diagnostic systems and geographical regions.

By Product Type:

• Polysomnography (PSG) Devices
• Ambulatory PSG Monitoring Devices
• Clinical PSG Monitoring Devices
• Sleep Apnea Screening Device
• Nasal Flow Sensors
• Peripheral Capillary Oxygen Saturation (SPO2)
• Actigraphy Monitoring Devices

By End-use:

• Home Care Settings
• Hospitals
• Sleep Centers & Clinics

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Sleep Apnea Diagnostic Systems Market Snapshot, 2023 and 2030
• 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Product Type Lifecycle Analysis
• 2.4. Sleep Apnea Diagnostic Systems Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2013-2016
  • 3.2.2. Current Market Size Forecast, 2018-2026
• 3.3. Global Sleep Apnea Diagnostic Systems Market Outlook: Product Type
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
    • 3.3.3.1. Polysomnography (PSG) Devices
    • 3.3.3.2. Ambulatory PSG Monitoring Devices
    • 3.3.3.3. Clinical PSG Monitoring Devices
    • 3.3.3.4. Sleep Apnea Screening Device
    • 3.3.3.5. Nasal Flow Home Care Settings
    • 3.3.3.6. Peripheral Capillary Oxygen Saturation (SPO2)
    • 3.3.3.7. Actigraphy Monitoring Devices
• 3.4. Market Attractiveness Analysis: Product Type
• 3.5. Global Sleep Apnea Diagnostic Systems Market Outlook: End User
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 3.5.3.1. Home Care Settings
    • 3.5.3.2. Hospitals
    • 3.5.3.3. Sleep Centers & Clinics
• 3.6. Market Attractiveness Analysis: End User

4. Global Sleep Apnea Diagnostic Systems Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia & Pacific
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 5.3.1. By Country
  • 5.3.2. By Product Type
  • 5.3.3. By End User
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 5.5.1. Polysomnography (PSG) Devices
  • 5.5.2. Ambulatory PSG Monitoring Devices
  • 5.5.3. Clinical PSG Monitoring Devices
  • 5.5.4. Sleep Apnea Screening Device
  • 5.5.5. Nasal Flow Sensors
  • 5.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 5.5.7. Actigraphy Monitoring Devices
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 5.6.1. Home Care Settings
  • 5.6.2. Hospitals
  • 5.6.3. Sleep Centers & Clinics
• 5.7. Market Attractiveness Analysis

6. Europe Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 6.3.1. By Country
  • 6.3.2. By Product Type
  • 6.3.3. By End User
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkey
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 6.5.1. Polysomnography (PSG) Devices
  • 6.5.2. Ambulatory PSG Monitoring Devices
  • 6.5.3. Clinical PSG Monitoring Devices
  • 6.5.4. Sleep Apnea Screening Device
  • 6.5.5. Nasal Flow Sensors
  • 6.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 6.5.7. Actigraphy Monitoring Devices
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 6.6.1. Home Care Settings
  • 6.6.2. Hospitals
  • 6.6.3. Sleep Centers & Clinics
• 6.7. Market Attractiveness Analysis

7. East Asia Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 7.3.1. By Country
  • 7.3.2. By Product Type
  • 7.3.3. By End User
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 7.5.1. Polysomnography (PSG) Devices
  • 7.5.2. Ambulatory PSG Monitoring Devices
  • 7.5.3. Clinical PSG Monitoring Devices
  • 7.5.4. Sleep Apnea Screening Device
  • 7.5.5. Nasal Flow Sensors
  • 7.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 7.5.7. Actigraphy Monitoring Devices
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 7.6.1. Home Care Settings
  • 7.6.2. Hospitals
  • 7.6.3. Sleep Centers & Clinics
• 7.7. Market Attractiveness Analysis

8. South Asia & Oceania Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 8.3.1. By Country
  • 8.3.2. By Product Type
  • 8.3.3. By End User
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 8.5.1. Polysomnography (PSG) Devices
  • 8.5.2. Ambulatory PSG Monitoring Devices
  • 8.5.3. Clinical PSG Monitoring Devices
  • 8.5.4. Sleep Apnea Screening Device
  • 8.5.5. Nasal Flow Sensors
  • 8.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 8.5.7. Actigraphy Monitoring Devices
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 8.6.1. Home Care Settings
  • 8.6.2. Hospitals
  • 8.6.3. Sleep Centers & Clinics
• 8.7. Market Attractiveness Analysis

9. Latin America Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 9.3.1. By Country
  • 9.3.2. By Product Type
  • 9.3.3. By End User
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 9.5.1. Polysomnography (PSG) Devices
  • 9.5.2. Ambulatory PSG Monitoring Devices
  • 9.5.3. Clinical PSG Monitoring Devices
  • 9.5.4. Sleep Apnea Screening Device
  • 9.5.5. Nasal Flow Sensors
  • 9.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 9.5.7. Actigraphy Monitoring Devices
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 9.6.1. Home Care Settings
  • 9.6.2. Hospitals
  • 9.6.3. Sleep Centers & Clinics
• 9.7. Market Attractiveness Analysis

10. Middle East & Africa Sleep Apnea Diagnostic Systems Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 10.3.1. By Country
  • 10.3.2. By Product Type
  • 10.3.3. By End User
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  • 10.5.1. Polysomnography (PSG) Devices
  • 10.5.2. Ambulatory PSG Monitoring Devices
  • 10.5.3. Clinical PSG Monitoring Devices
  • 10.5.4. Sleep Apnea Screening Device
  • 10.5.5. Nasal Flow Sensors
  • 10.5.6. Peripheral Capillary Oxygen Saturation (SPO2)
  • 10.5.7. Actigraphy Monitoring Devices
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 10.6.1. Home Care Settings
  • 10.6.2. Hospitals
  • 10.6.3. Sleep Centers & Clinics
• 10.7. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2022
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Ambulatory PSG Monitoring Devices
  • 11.2.3. Apparent Product Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Koninklijke Philips N.V.
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Product
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. Becton, Dickinson and Company
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Product
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Braedon Medical Corporation
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Product
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. Advanced Brain Monitoring Inc.
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Product
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. SOMNOmedics GmbH
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Product
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. ResMed Inc.
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Product
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. BMC Medical Co. Ltd.
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Product
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Natus Medical Incorporated
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Product
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. MGC Diagnostics Corporation
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Product
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Cleveland Medical Devices Inc.
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Product
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations